The -56T HLA-G promoter polymorphism is not associated with pre-eclampsia/eclampsia in Australian and New Zealand women

Hypertension in Pregnancy

Volumn 25, Issue 2, 2006, Pages 63-71

  Doherty, Vicki ^a   Rush, Ashley ^a   Brennecke, Shaun ^a,b   Moses, Eric ^a,b  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Allelic discrimination; HLA G; Pre eclampsia; Promoter polymorphism

Indexed keywords

GUANINE NUCLEOTIDE; HLA G ANTIGEN; PYRIMIDINE NUCLEOTIDE;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGEN EXPRESSION; ARTICLE; BASE PAIRING; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; ECLAMPSIA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NULLIPARA; PREECLAMPSIA; PREGNANCY DISORDER; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRANSCRIPTION INITIATION SITE;

AUSTRALIA; CASE-CONTROL STUDIES; ECLAMPSIA; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; NEW ZEALAND; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS (GENETICS); THYMINE;

EID: 33746826041     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950500543780     Document Type: Article

References (26)

1. Sibai B, Dekker G, Kupfermic M. Pre-eclampsia. Lancet 2005; 365:785-799.
2. Lachmeijer AM, Dekker GA, Pals G, Aarnoudse JG, ten Kate LP, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstet Gynecol Reprod Biol 2002; 105:94-113.
3. Le Bouteiller P, Pizzato N, Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 2003; 59:219-234.
4. Le Bouteiller P, Blaschitz A. The functionality of HLA-G is emerging. Immunol Rev 1999; 167:233-244.
5. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000; 6:88-95.
6. Matte C, Lacaille J, Zijenah L, Ward B, Roger M. HLA-G exhibits low level of polymorphism in indigenous East Africans. Hum Immunol 2002; 63:495-501.
7. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, Varner MW. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 2001; 344:867-872.
8. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LK, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ.
9. Wilton AN, Cooper DW, Brennecke SP, Bishop SM, Marshall P. Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/ eclampsia and HLA DR beta. Lancet 1990; 336:653-657.
10. Lade JA, Moses EK, Guo G, Wilton AN, Grehan M, Cooper DW, Brennecke SP. The eNOS gene: a candidate for the preeclampsia susceptibility locus? Hypertens Pregnancy 1999; 18:81-93.
11. Moses EK, Lade JA, Guo G, Wilton AN, Grehan M, Freed K, Borg A, Terwilliger JD, North R, Cooper DW, Brennecke SP. A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2. Am J Hum Genet 2000; 67:1581-1585.
12. Higgins JR, Kaiser T, Moses EK, North R, Brennecke SP. Prothrombin G20210A mutation: is it associated with pre-eclampsia? Gynecol Obstet Invest 2000; 50:254-257.
13. Kaiser T, Brennecke SP, Moses EK. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women. Gynecol Obstet Invest 2000; 50:100-102.
14. Kaiser T, Grehan M, Brennecke SP, Moses EK. Association of the TNF2 Allele with Eclampsia. Gynecol Obstet Invest 2004; 57:204-209.
15. Fitzpatrick E, Goring H, Liu H, Borg A, Forrest S, Cooper DW, Brennecke SP, Moses EK. Fine mapping and SNP analysis of positional candidates at the pre-eclampsia susceptibility locus PREG1, on chromosome 2. Hum Biol 2004; 76:849-862.
16. Brown MA, Gallery EDM, Gatt SP, Leslie G, Robinson J. Management of hypertension in pregnancy: Executive summary. Med J Aust 1993; 158:700-702.
17. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274:792-795.
18. Ishitani A, Sageshima N, Lee N, Dorofeeva N, Hatake K, Marquardt H, Geraghty DE. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003; 171:1376-1384.
19. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS. HLA-G1 protein expression is not essential for fetal survival. Placenta 1998; 19:127-132.
20. Menier C, Riteau B, Dausset J, Carosella ED, Rouas-Freiss N. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival. Hum Immunol 2000; 61:1118-1125.
21. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vitro fertilization and pregnancy outcome. Tissue Antigens 2004; 64:66-69.
22. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL, Hyslop T. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003; 72:1425-1435.
23. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004; 10:237-246.
24. Hviid TV. HLA-G genotype is associated with fetoplacental growth. Hum Immunol 2004; 65:586-593.
25. Yamashita T, Fujii T, Tokunaga K, Tadokoro K, Hamai Y, Miki A, Kozuma S, Juji T, Taketani Y. Analysis of human leukocyte antigen-G polymorphism including intron 4 in Japanese couples with habitual abortion. Am J Reprod Immunol 1999; 41:159-163.
26. Penzes M, Rajczy K, Gyodi E, Reti M, Feher E, Petranyi G. HLA-G gene polymorphism in the normal population and in recurrent spontaneous abortion in Hungary. Transplant Proc 1999; 31:1832-1833.